During the past decade, China Medical University Hsinchu Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "China Medical University Hsinchu Hospital" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "China Medical University Hsinchu Hospital" are "Colorectal Cancer; Lung Cancer" (1 trials) and "Postoperative Pain" (1 trials). Many other conditions were trialed in "China Medical University Hsinchu Hospital" in a lesser frequency.

Most popular intervention types in "China Medical University Hsinchu Hospital" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ERDS group" (1 trials), "PCA group" (1 trials), "Regorafenib Pill" (1 trials), "TAS-102 pill" (1 trials) and "TATE and pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "China Medical University Hsinchu Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "China Medical University Hsinchu Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in China Medical University Hsinchu Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in China Medical University Hsinchu Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".